₹ 111.39 Cr
2.36%
S&P BSE Healthcare TRI
INF03VN01878
100.0
100.0
0
Piyush Baranwal, Ramesh Mantri, Dheeresh Pathak
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth | - | - | - |
S&P BSE Healthcare TRI | 50.08 | 13.58 | 22.23 |
Equity
Debt
Others
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
Company | Holdings (%) |
---|---|
Sun Pharmaceutical Industries Ltd. | 9.53 |
Cipla Ltd. | 8.93 |
Torrent Pharmaceuticals Ltd. | 6.27 |
Zydus Lifesciences Ltd. | 5.33 |
Poly Medicure Ltd. | 3.95 |
Divi's Laboratories Ltd. | 3.9 |
Max Healthcare Institute Ltd. | 3.8 |
Mankind Pharma Ltd. | 3.72 |
Ajanta Pharma Ltd. | 3.72 |
Lupin Ltd. | 3.41 |
Sector | Holdings (%) |
---|---|
Healthcare | 98.12 |
Financial | 1.64 |
Chemicals | 1.03 |
N/A | 0.03 |
Others | -0.82 |